|Articles|November 1, 2003
Assess Flap Viability
New Orleans - A small, hand-held, nonpulsatile, optical diffusion oximeter (FireFly Tissue Oximeter, Spectros) shows promise as a tool for assessing flap viability and, thereby, enabling intraoperative modifications, postoperative revisions, and ultimately outcomes of flap reconstruction surgery, according to the results of a pilot study conducted by researchers in the department of dermatology, Stanford University, Stanford, Calif.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5













